Identification of a Novel EML4-ALK Fusion Transcript in Lung Adenocarcinoma

被引：0
|
作者：
To, K. [1 ]
Tong, J. H. M. [1 ]
Law, P. P. Y. [1 ]
Chau, S. L. [1 ]
Lung, R. W. M. [1 ]
Yeung, S. F. [1 ]
Kang, W. [1 ]
机构：
[1] Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2012年 / 7卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S218 / S219
页数：2
相关论文
共 50 条
  • [41] The EML4-ALK transcript but not the fusion protein can be expressed in reactive and neoplastic lymphoid tissues
    Sozzi, Gabriella
    Martelli, Maria Paola
    Conte, Davide
    Modena, Piergiorgio
    Pettirossi, Valentina
    Pileri, Stefano A.
    Falini, Brunangelo
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (09): : 1307 - 1311
  • [42] A Case of Lung Adenocarcinoma Resistant to Crizotinib Harboring a Novel EML4-ALK Variant, Exon 6 of EML4 Fused to Exon 18 of ALK
    Anai, Satoshi
    Takeshita, Masafumi
    Ando, Nobuhisa
    Ikematsu, Yuuki
    Mishima, Shohei
    Ishida, Koichi
    Inoue, Kouji
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (10) : E126 - +
  • [43] A rare double ALK fusion variant EML4-ALK and CDK15-ALK in lung adenocarcinoma and response to crizotinib A case report
    Guo, Jun
    Shi, Junping
    Yao, Ming
    Jin, Yi
    Liu, Dengxiang
    Liu, Weiling
    Wang, Kai
    Jiang, Da
    [J]. MEDICINE, 2020, 99 (45) : E22631
  • [44] Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
    Soda, Manabu
    Choi, Young Lim
    Enomoto, Munehiro
    Takada, Shuji
    Yamashita, Yoshihiro
    Ishikawa, Shunpei
    Fujiwara, Shin-ichiro
    Watanabe, Hideki
    Kurashina, Kentaro
    Hatanaka, Hisashi
    Bando, Masashi
    Ohno, Shoji
    Ishikawa, Yuichi
    Aburatani, Hiroyuki
    Niki, Toshiro
    Sohara, Yasunori
    Sugiyama, Yukihiko
    Mano, Hiroyuki
    [J]. NATURE, 2007, 448 (7153) : 561 - U3
  • [45] EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers
    Inamura, Kentaro
    Takeuchi, Kengo
    Togashi, Yuki
    Nomura, Kimie
    Ninomiya, Hironori
    Okui, Michiyo
    Satoh, Yukitoshi
    Okumura, Sakae
    Nakagawa, Ken
    Soda, Manabu
    Choi, Young Lim
    Niki, Toshiro
    Mano, Hiroyuki
    Ishikawa, Yuichi
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (01) : 13 - 17
  • [46] Signet ring cell adenocarcinoma of the lung with an EML4-ALK fusion gene mimicking mucinous (colloid) adenocarcinoma: A case report
    Ohba, Taro
    Sugio, Kenji
    Kometani, Takuro
    Yamaguchi, Masafumi
    Hamatake, Motoharu
    Nosaki, Kaname
    Takeoka, Hiroaki
    Kitajima, Hiromoto
    Hirai, Fumihiko
    Seto, Takashi
    Taguchi, Kenichi
    Nishiyama, Kenichi
    Shida, Yoshitaka
    Ichinose, Yukito
    [J]. LUNG CANCER, 2011, 73 (03) : 375 - 378
  • [47] A RATIONAL DIAGNOSTIC ALGORITHM FOR THE IDENTIFICATION OF EML4-ALK TRANSLOCATION IN LUNG CANCER
    Takamochi, Kazuva
    Oh, Shiaki
    Suzuki, Kenji
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S462 - S462
  • [48] Dual drive coexistence of EML4-ALK and TPM3-ROS1 fusion in advanced lung adenocarcinoma
    Zhu, You-cai
    Liao, Xing-hui
    Wang, Wen-xian
    Xu, Chun-wei
    Zhuang, Wu
    Wei, Jian-guo
    Du, Kai-qi
    [J]. THORACIC CANCER, 2018, 9 (02) : 324 - 327
  • [49] Neoadjuvant target therapy with ensartinib in lung adenocarcinoma with EML4-ALK fusion variant: a case report and literature review
    Wu, Yimin
    Huang, Lijian
    Li, Wenshan
    Chai, Ying
    [J]. ANTI-CANCER DRUGS, 2023, 34 (05) : 699 - 706
  • [50] Identification of an EML4-ALK rearrangement in an intrahepatic cholangiocarcinoma
    Favre, Loetitia
    Pujals, Anais
    Maille, Pascale
    Poullot, Elsa
    Calderaro, Julien
    [J]. PATHOLOGY INTERNATIONAL, 2021, 71 (09) : 630 - 632
12345